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Flexible tumor metabolism
T
umor cells can survive the hypoxia in the 
center of tumor masses by using glycolysis, 
rather than oxidative phosphorylation, to 
generate energy. Most tumor cells also stick to 
glycolysis when normally oxygenated. Valeria 
Fantin, Julie St-Pierre, and Philip Leder (Harvard 
Medical School, Boston, MA) now report that 
some tumor cells, despite their preference for 
glycolysis, nevertheless retain the ability to use 
oxidative phosphorylation.
The Boston team reached this conclusion by in-
hibiting lactate dehydrogenase A (LDH-A). This en-
zyme converts NADH and pyruvate, the products of 
glycolysis, into lactate and NAD+. The lactate is ex-
ported and the NAD+ used to keep glycolysis going.
Therefore, when LDH-A is shut off and oxygen 
is limited, NAD+ runs low and glycolysis alone 
cannot continue. When oxygen is around, however, 
the pyruvate can be converted to acetyl-CoA to 
feed the Krebs cycle, which in turn feeds oxidative 
phosphorylation to regenerate NAD+.
It was unclear whether tumor cells were capable 
of switching back to oxidative phosphorylation. It 
now seems that some are: some cells inhibited for 
LDH-A got their mitochondria going and grew 
almost as well as wild-type cells if oxygen levels 
were normal. The inhibited cells did poorly in low-
oxygen and in tumor models, however.
A preference for glycolysis in normoxic condi-
tions, even by cells perfectly capable of oxidative 
phosphorylation, is somewhat of a surprise given 
the greater effi  ciency (per glucose molecule) of oxi-
dative phosphorylation. But in fact oxidative phos-
phorylation is slower than glycolysis. This difference 
may be critical for fast-growing tumor cells.
The bias toward glycolysis is probably driven 
by HIF-1α, which is induced by both hypoxia and 
oncogenes, and by oncogenes that increase glucose 
uptake. Normal cells rely far less on glycolysis and 
LDH-A, however, so anticancer therapies targeting 
LDH-A should be nontoxic.
Reference: Fantin, V., et al. 2006. Cancer Cell. 
9:425–434.
Seeing tube formation
M
akoto Kamei, Brant Weinstein (NIH, Bethesda, MD), and 
colleagues have visualized in vivo tubule formation. As in pre-
vious in vitro experiments, large vacuoles fuse to form a tubule 
lumen that passes through an individual cell. Many such cells adhere in 
a line to form a blood vessel.
The researchers took advantage of the transparency of zebraﬁ  sh to look 
at vessels emerging from the dorsal aorta. Initially, they saw highly dynamic 
vacuoles that appeared and disappeared. The vacuoles then fused together 
and enlarged to take up most of the cell volume, thus forming the lumen.
Quantum dots injected into the circulation got into the lumen formed by 
each cell in turn. Preliminary evidence suggests that vacuoles form indepen-
dently in each cell, but enlargement may be a progressive process: the cells 
nearest to established vessels may help out their more distal neighbors.
The tubulating vacuoles formed in vitro are pinocytic in origin. 
Given the visual similarities, the same may be true in vivo. Weinstein 
suggests that these vacuoles may mature by establishing their identity as 
apical membranes, as the inside of a tubule is ultimately deﬁ  ned as api-
cal. He now plans to track apical markers in transgenic zebraﬁ  sh.
Reference: Kamei, M., et al. 2006. Nature. doi:10.1038/nature04923.
Mixed kinetochore fiber
T
he action of a single kinetochore fi  ber 
appears unifi  ed—it is either pulling or 
pushing its attached chromosome at any 
given time. But underlying this unity is diversity, 
say Kristin VandenBeldt, Bruce McEwen 
(Wadsworth Center, New York State Department 
of Health, Albany, NY), and colleagues. They 
fi  nd that the kinetochore microtubules (kMTs) 
in a single fi  ber are a mixture of depolymerizing 
and polymerizing microtubules.
The concept of unifi  ed kinetochore action 
came from light microscopy. But when the 
New York team used electron microscopy 
they saw that the 10–30 kMTs in one fi  ber had a mixture of morphologies. The 
kMTs with straight ends at the kinetochore are believed to be polymerizing, 
whereas those with curved ends are the unravelling depolymerizing kMTs. 
Surprisingly, two-thirds of kMTs were in the depolymerizing state during 
metaphase, suggesting that the kinetochore restrains kMTs that are in the depolymerizing state and retards 
their shrinkage. This restraint should produce the tension that is central to spindle dynamics.
Some kinetochores had fewer depolymerizing kMTs and some had more, but the differences were on a continuum. 
Thus the kinetochore appears to change direction based on a balance of pulling and pushing forces rather than a discrete, 
all-or-none switch. How the polymerization bias and kMT detachment are controlled remains largely mysterious.
Reference: VandenBeldt, K.J., et al. 2006. Curr. Biol. 16:1217–1223.
Red dye enters ﬁ  rst one and then two cells of a zebraﬁ  sh vessel sprout.
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Polymerizing (left) and depoly-
merizing (right) microtubules 
are found in different mixtures 
at kinetochores (bottom).
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